cysteine has been researched along with Pulmonary Hypertension in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Huang, S; Tang, L; Wang, N; Wang, P; Wei, X; Zhang, L; Zheng, Y | 1 |
| Chen, S; Cui, H; Du, GQ; Li, Y; Shen, W; Sun, P; Wang, C; Xue, JY; Zhao, P | 1 |
| Ho, WJ; Lai, YJ; Yeh, YH; Yen, TH | 1 |
| Bu, D; Chen, S; Du, J; Huang, Y; Jin, H; Kong, W; Liu, X; Tang, C; Tang, X; Tao, Y; Wang, X; Yang, G; Yu, W; Zhang, D; Zhang, H | 1 |
| Guo, J; Huo, S; Li, S; Lin, L; Luo, P; Lv, J; Peng, L; Shi, W; Wang, M; Yan, D; Zhang, C | 1 |
| Ban, Y; Chen, C; Chen, S; Gu, Y; Li, Y; Liu, Y; Wang, N; Xiao, L; Zhang, Y; Zhao, B | 1 |
| Chelikani, P; Dakshinamurti, S; Hinton, M; Santhosh, KT; Sikarwar, AS | 1 |
| Al Kassem, H; Eapen, DJ; Ghasemzadeh, N; Jones, DP; Khayata, M; Manocha, P; Patel, RS; Quyyumi, AA; Sperling, L; Veledar, E; Zafari, AM | 1 |
| Lin, HC; Ma, L; Neu, J; Zhou, P | 1 |
| Djordjevic, V; Kovac, M; Mitic, G; Pruner, I; Radojkovic, D | 1 |
| Auten, RL; Brahmajothi, MV; McMahon, TJ; Tinch, BT; Torok, JA; Zhu, H | 1 |
| Chan, SY; Handy, DE; Leopold, JA; Loscalzo, J; Mahoney, CE; Maron, BA; White, K; Zhang, YY | 1 |
| Berezné, A; Guillevin, L; Mouthon, L; Poiraudeau, S | 1 |
| Giraud, GD; Starr, A; Stuesse, DC; Trunkey, DD; Vlessis, AA | 1 |
2 review(s) available for cysteine and Pulmonary Hypertension
| Article | Year |
|---|---|
Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia.
Topics: Acetylcysteine; Antioxidants; Arginine; Bronchopulmonary Dysplasia; Citrulline; Cysteine; Fatty Acids, Unsaturated; Glutamine; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Infant, Premature; Inositol; Selenium; Vitamin A; Vitamin B Complex | 2017 |
[Therapeutic management of systemic sclerosis].
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cyclophosphamide; Cysteine; Epoprostenol; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Interferons; Lung Diseases, Interstitial; Orthotic Devices; Penicillamine; Peripheral Blood Stem Cell Transplantation; Physical Therapy Modalities; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Scleroderma, Systemic; Vasodilator Agents | 2006 |
12 other study(ies) available for cysteine and Pulmonary Hypertension
| Article | Year |
|---|---|
Cysteine and glycine-rich protein 2 promotes hypoxic pulmonary vascular smooth muscle cell proliferation through the Wnt3α-β-catenin/lymphoid enhancer-binding factor 1 pathway.
Topics: Actins; beta Catenin; Cell Proliferation; Cells, Cultured; Cysteine; Glycine; Humans; Hypertension, Pulmonary; Hypoxia; Lymphoid Enhancer-Binding Factor 1; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Vascular Remodeling | 2022 |
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Arginine Vasopressin; Cysteine; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hepatocyte Growth Factor; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Malondialdehyde; Melatonin; Monocrotaline; NF-E2-Related Factor 2; Proto-Oncogene Proteins; Pulmonary Arterial Hypertension; Rats; RNA, Small Interfering; Ventricular Remodeling | 2022 |
Cathepsin S Inhibition Suppresses Experimental Systemic Lupus Erythematosus-Associated Pulmonary Arterial Remodeling.
Topics: Animals; Cathepsins; Cysteine; Disease Models, Animal; Female; Hypertension, Pulmonary; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; PPAR gamma; Vascular Remodeling | 2022 |
Endogenous hydrogen sulfide sulfhydrates IKKβ at cysteine 179 to control pulmonary artery endothelial cell inflammation.
Topics: Animals; Cells, Cultured; Cysteine; Cytokines; Down-Regulation; Endothelial Cells; Endothelium, Vascular; Humans; Hydrogen Sulfide; Hypertension, Pulmonary; I-kappa B Kinase; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Male; Monocrotaline; NF-kappa B; Pulmonary Artery; Rats, Wistar; Signal Transduction | 2019 |
S-Nitroso-L-Cysteine Ameliorated Pulmonary Hypertension in the MCT-Induced Rats through Anti-ROS and Anti-Inflammatory Pathways.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Movement; Collagen; Cysteine; Endoplasmic Reticulum Stress; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; MAP Kinase Signaling System; Matrix Metalloproteinases; Mitophagy; Monocrotaline; Muscle Contraction; Muscle, Smooth; Oxidative Stress; Phosphorylation; Rats, Sprague-Dawley; Reactive Oxygen Species; S-Nitrosothiols; STAT3 Transcription Factor; Vascular Remodeling; Wound Healing | 2021 |
S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension.
Topics: Animals; Cysteine; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hypertension, Pulmonary; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Protein Transport; Rats; Recombinant Proteins; Transcription, Genetic; Vasodilation | 2019 |
Palmitoylation of Gαq determines its association with the thromboxane receptor in hypoxic pulmonary hypertension.
Topics: Animals; Animals, Newborn; Calcium; Cells, Cultured; Cysteine; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Hypertension, Pulmonary; Hypoxia; Lipoylation; Muscle Cells; Prostaglandins; Pulmonary Artery; Receptors, Thromboxane; Swine; Thromboxanes; Vasoconstriction | 2014 |
Oxidative stress is associated with increased pulmonary artery systolic pressure in humans.
Topics: Aged; Blood Pressure; Cysteine; Cystine; Echocardiography; Female; Glutathione; Glutathione Disulfide; Humans; Hypertension, Pulmonary; Linear Models; Male; Middle Aged; Mitral Valve Insufficiency; Multivariate Analysis; Oxidative Stress; Pulmonary Artery; Stroke Volume | 2014 |
Are thrombophilia more multifactorial than we thought: report of mosaicism for FII G20210A and novel FII T20061C gene variants.
Topics: Alanine; Biomarkers; Cysteine; Female; Genotype; Glycine; Humans; Hypertension, Pulmonary; Middle Aged; Mosaicism; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prothrombin; Pulmonary Embolism; Recurrence; Risk Factors; Threonine; Thrombophilia | 2012 |
Transpulmonary flux of S-nitrosothiols and pulmonary vasodilation during nitric oxide inhalation: role of transport.
Topics: Administration, Inhalation; Amino Acids, Cyclic; Animals; Biological Transport, Active; Cysteine; Female; Hypertension, Pulmonary; Leucine; Lung; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; S-Nitrosothiols; Vasodilation | 2012 |
Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.
Topics: Aldosterone; Animals; Cells, Cultured; Cysteine; Disease Models, Animal; Endothelial Cells; Endothelin-1; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Male; Mineralocorticoid Receptor Antagonists; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Pulmonary Artery; Pulmonary Wedge Pressure; Rats; Rats, Sprague-Dawley; Receptor, Endothelin B; Spironolactone; Sulfhydryl Compounds | 2012 |
Hemodynamic effects of S-nitrosocysteine, an intravenous regional vasodilator.
Topics: Analysis of Variance; Animals; Cysteine; Hemodynamics; Hypertension, Pulmonary; Infusions, Intra-Arterial; Nitroso Compounds; Pulmonary Circulation; S-Nitrosothiols; Swine; Vascular Resistance; Vasodilator Agents | 2001 |